1. Home
  2. VERU vs RMI Comparison

VERU vs RMI Comparison

Compare VERU & RMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • RMI
  • Stock Information
  • Founded
  • VERU 1971
  • RMI 2018
  • Country
  • VERU United States
  • RMI United States
  • Employees
  • VERU N/A
  • RMI N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • RMI Finance/Investors Services
  • Sector
  • VERU Health Care
  • RMI Finance
  • Exchange
  • VERU Nasdaq
  • RMI Nasdaq
  • Market Cap
  • VERU 85.5M
  • RMI 91.2M
  • IPO Year
  • VERU 1990
  • RMI N/A
  • Fundamental
  • Price
  • VERU $0.49
  • RMI $13.88
  • Analyst Decision
  • VERU Strong Buy
  • RMI
  • Analyst Count
  • VERU 2
  • RMI 0
  • Target Price
  • VERU $4.00
  • RMI N/A
  • AVG Volume (30 Days)
  • VERU 1.4M
  • RMI 17.4K
  • Earning Date
  • VERU 08-07-2025
  • RMI 01-01-0001
  • Dividend Yield
  • VERU N/A
  • RMI 7.28%
  • EPS Growth
  • VERU N/A
  • RMI N/A
  • EPS
  • VERU N/A
  • RMI N/A
  • Revenue
  • VERU $16,886,419.00
  • RMI N/A
  • Revenue This Year
  • VERU N/A
  • RMI N/A
  • Revenue Next Year
  • VERU N/A
  • RMI N/A
  • P/E Ratio
  • VERU N/A
  • RMI N/A
  • Revenue Growth
  • VERU 134.43
  • RMI N/A
  • 52 Week Low
  • VERU $0.45
  • RMI $13.05
  • 52 Week High
  • VERU $1.42
  • RMI $17.37
  • Technical
  • Relative Strength Index (RSI)
  • VERU 35.42
  • RMI 35.27
  • Support Level
  • VERU $0.49
  • RMI $14.09
  • Resistance Level
  • VERU $0.61
  • RMI $14.00
  • Average True Range (ATR)
  • VERU 0.04
  • RMI 0.15
  • MACD
  • VERU -0.01
  • RMI -0.03
  • Stochastic Oscillator
  • VERU 2.27
  • RMI 7.46

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About RMI RiverNorth Opportunistic Municipal Income Fund Inc.

RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

Share on Social Networks: